S&P 500   4,109.31
DOW   33,274.15
QQQ   320.93
MarketBeat Week in Review – 3/27 - 3/31
5 Stocks to Buy Immediately (Ad)pixel
Intensity and insults rise as lawmakers debate debt ceiling
UK travelers face hours-long waits for ferries to France
5 Stocks to Buy Immediately (Ad)pixel
Credit Suisse takeover hits heart of Swiss banking, identity
Small areas reopen near Fukushima nuclear plant, few return
5 Stocks to Buy Immediately (Ad)pixel
UN food chief: Billions needed to avert unrest, starvation
'War of the states': EV, chip makers lavished with subsidies
S&P 500   4,109.31
DOW   33,274.15
QQQ   320.93
MarketBeat Week in Review – 3/27 - 3/31
5 Stocks to Buy Immediately (Ad)pixel
Intensity and insults rise as lawmakers debate debt ceiling
UK travelers face hours-long waits for ferries to France
5 Stocks to Buy Immediately (Ad)pixel
Credit Suisse takeover hits heart of Swiss banking, identity
Small areas reopen near Fukushima nuclear plant, few return
5 Stocks to Buy Immediately (Ad)pixel
UN food chief: Billions needed to avert unrest, starvation
'War of the states': EV, chip makers lavished with subsidies
S&P 500   4,109.31
DOW   33,274.15
QQQ   320.93
MarketBeat Week in Review – 3/27 - 3/31
5 Stocks to Buy Immediately (Ad)pixel
Intensity and insults rise as lawmakers debate debt ceiling
UK travelers face hours-long waits for ferries to France
5 Stocks to Buy Immediately (Ad)pixel
Credit Suisse takeover hits heart of Swiss banking, identity
Small areas reopen near Fukushima nuclear plant, few return
5 Stocks to Buy Immediately (Ad)pixel
UN food chief: Billions needed to avert unrest, starvation
'War of the states': EV, chip makers lavished with subsidies
S&P 500   4,109.31
DOW   33,274.15
QQQ   320.93
MarketBeat Week in Review – 3/27 - 3/31
5 Stocks to Buy Immediately (Ad)pixel
Intensity and insults rise as lawmakers debate debt ceiling
UK travelers face hours-long waits for ferries to France
5 Stocks to Buy Immediately (Ad)pixel
Credit Suisse takeover hits heart of Swiss banking, identity
Small areas reopen near Fukushima nuclear plant, few return
5 Stocks to Buy Immediately (Ad)pixel
UN food chief: Billions needed to avert unrest, starvation
'War of the states': EV, chip makers lavished with subsidies
NASDAQ:GBT

Global Blood Therapeutics - GBT Insider Trading & Ownership

Notice: This company has been marked as potentially delisted and may not be actively trading.
Add
Compare
Today's Range
$68.49
▼
$68.49
50-Day Range
$68.07
▼
$68.49
52-Week Range
$21.65
▼
$73.02
Volume
74 shs
Average Volume
2.07 million shs
Market Capitalization
$4.62 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$67.75

Global Blood Therapeutics (NASDAQ:GBT) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
4.90%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
2
Amount Of
Insider Selling
(Last 12 Months)
$348,649.82

GBT Insider Buying and Selling by Quarter

Get GBT Insider Trade Alerts

Want to know when executives and insiders are buying or selling Global Blood Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Global Blood Therapeutics Insider Trades History

Export to Excel
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/18/2022Nazila HabibizadInsiderSell4,678$67.19$314,314.828,918  
6/21/2022Philip A PizzoDirectorSell1,260$27.25$34,335.009,112  
(Data available from 1/1/2013 forward)












GBT Insider Trading Activity - Frequently Asked Questions

Who is on Global Blood Therapeutics's Insider Roster?

The list of insiders at Global Blood Therapeutics includes Dawn Svoronos, Eric Fink, Jeffrey S Farrow, Lesley Ann Calhoun, Mark L Perry, Nazila Habibizad, Philip A Pizzo, Scott W Morrison, Ted W Love, and Tricia Borga Suvari. Learn more on insiders at GBT.

What percentage of Global Blood Therapeutics stock is owned by insiders?

4.90% of Global Blood Therapeutics stock is owned by insiders. Learn more on GBT's insider holdings.

Which Global Blood Therapeutics insiders have been buying company stock?

The following insider purchased GBT shares in the last 24 months: Eric Fink ($18,980.00).

How much insider buying is happening at Global Blood Therapeutics?

Insiders have purchased a total of 500 GBT shares in the last 24 months for a total of $18,980.00 bought.

Which Global Blood Therapeutics insiders have been selling company stock?

The following insiders have sold GBT shares in the last 24 months: Nazila Habibizad ($314,314.82), Philip A Pizzo ($73,250.10), and Scott W Morrison ($145,008.00).

How much insider selling is happening at Global Blood Therapeutics?

Insiders have sold a total of 11,803 Global Blood Therapeutics shares in the last 24 months for a total of $532,572.92 sold.

This page (NASDAQ:GBT) was last updated on 4/1/2023 by MarketBeat.com Staff